These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 12534042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [Abstract] [Full Text] [Related]

  • 3. The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency.
    Yordam N, Kandemir N, Alikaşifoğlu A.
    Turk J Pediatr; 1998; 40(1):55-60. PubMed ID: 9673529
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [Abstract] [Full Text] [Related]

  • 7. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Jul; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

  • 8. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Jul; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 10. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D, Garel C, Limoni C, Czernichow P, Léger J.
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [Abstract] [Full Text] [Related]

  • 11. An auxology-based growth hormone program: update on the Australian experience.
    Werther GA, Wang M, Cowell CT.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():613-8. PubMed ID: 12795362
    [Abstract] [Full Text] [Related]

  • 12. [The model of height prognosis in children with growth hormone deficiency].
    Kostecka L, Wasikowa R, Noczyńska A, Filipowski H.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 May; 10(2):113-7. PubMed ID: 15504314
    [Abstract] [Full Text] [Related]

  • 13. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS, Scheinowitz M, Laron Z.
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A, Obara-Moszyńska M, Korman E, Rabska-Pietrzak B, Kopinski P, Trojan J, Goździcka-Józefiak A.
    Rocz Akad Med Bialymst; 2003 Mar; 48():28-33. PubMed ID: 14737937
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment.
    Wu KH, Tsai FJ, Peng CT.
    Ann Hematol; 2003 Oct; 82(10):637-40. PubMed ID: 12898188
    [Abstract] [Full Text] [Related]

  • 16. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
    Frindik JP, Kemp SF, Hunold JJ.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():607-12. PubMed ID: 12795361
    [Abstract] [Full Text] [Related]

  • 17. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 18. [Final results of the administration of biosynthetic growth hormone. Preliminary report].
    Mendoza-Morfín F, Cárdenas-Tirado H, Montero-González P, Bravo-Ríos LE, Gutiérrez-Avila C, Torres-Tamayo M.
    Gac Med Mex; 1998 Nov; 134(1):1-7. PubMed ID: 9658693
    [Abstract] [Full Text] [Related]

  • 19. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [Abstract] [Full Text] [Related]

  • 20. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.